FDA Drug Application (205649) for XIGDUO XR by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number205649
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 5MG BASE;500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXIGDUO XR
Active IngredientDAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DAPAGLIFLOZIN PROPANEDIOL2
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32


Back to FDA Applications sponsored by ASTRAZENECA AB